Abstracts tagged "sarcopenia and axial spondyloarthritis"

Abstract Number: 569 • 2019 ACR/ARP Annual Meeting
Sarcopenia, Segmental Muscle Strength and Body Composition in Young Axial Spondylarthritis Patients: Results from MyoSpA Study
Agna Neto¹, Rita Pinheiro Torres ², Lúcia Domingues ³, Diana Teixeira ⁴, Santiago Rodrigues-Manica ⁵, José Marona ², Carina Lopes ⁶, João Lagoas Gomes ², Tiago Costa ², Maria João Gonçalves ², Inês Silva ⁷, Paula Araújo ⁷, Margarida Mateus ⁷, Walter Castelão ⁷, Manuela Costa ⁷, Sandra Falcão ⁷, Ana Filipa Mourão ⁶, Atlas Sardoo ³, Sara Maia ³, Alexandre Sepriano ⁸, Sofia Ramiro ⁹, Conceição Calhau ⁴, Jaime Branco ⁵ and Fernando Pimentel-Santos ⁵, ¹Rheumatology Department, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental; CEDOC, NOVA Medical School, Faculdade de Ciências Médicas, Lisbon; Hospital Central do Funchal, Madeira., Lisbon, Portugal, ²Rheumatology Department, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental; CEDOC, NOVA Medical School, Faculdade de Ciências Médicas, Lisbon., Lisbon, Portugal, ³CEDOC, NOVA Medical School, Faculdade de Ciências Médicas, Lisbon, Lisbon, Portugal, ⁴Nutrition and Metabolism, NOVA Medical School, Faculdade de Ciências Médicas, Lisbon; CINTESIS, Lisbon, Lisbon, Portugal, ⁵CEDOC, NOVA-Medical School | Hospital Egas Moniz, CHLO, Lisbon, Lisbon, Portugal, ⁶Rheumatology Department, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental; CEDOC, NOVA Medical School, Faculdade de Ciências Médicas, Lisbon, Lisbon, Portugal, ⁷Rheumatology Department, Hospital de Egas Moniz, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal, ⁸Leiden University Medical Center, Leiden, Netherlands, ⁹Leiden University Medical Center and Zuyderland Medical Centre, Leiden, Netherlands
Background/Purpose: Sarcopenia is a generalized skeletal muscle disorder characterized by the loss of muscle strength and muscle mass, leading to functional limitation, worse quality of…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].